Opinion: Making healthcare more expensive -- bipartisanship s...
She is identified as one of the bipartisan Senate leaders behind a bill requiring insurance coverage for genetic testing.

SOURCE CHECK
TAP FOR WHYThe Wilson Times is a local news publisher, but this page presents an outside columnist’s argument rather than original reporting. The author’s stated role with a libertarian advocacy journalism organization makes the piece’s perspective clear, while offering little basis for judging its reporting standards or corrections practices.
- Source type — A local news publisher provides some institutional credibility.
- Author attribution — The author is named and his affiliation with the William Lloyd Garrison Center is disclosed.
- Editorial standards — This is explicitly an opinion column, not a reported news article.
- Track record — The article itself provides limited evidence for assessing the publisher’s broader reporting record.
The column clearly presents its argument and includes a quoted description of the bill and a cost estimate. Its claims about the effects of coverage mandates and the motives of lawmakers and industry interests are largely asserted rather than supported with independent evidence or counterarguments.
HOW WE SCORE ↗This is a one-sided opinion column. It acknowledges the value of early cancer detection but does not present supporters’ reasoning for requiring coverage or evidence addressing the columnist’s cost claims.
- Counterarguments presented — The column does not give proponents’ reasons for the coverage mandate.
- Source diversity — The argument is mainly the columnist’s, with only a short excerpt describing the bill.
- Loaded language — The column uses dismissive phrasing about lawmakers and their motives.
- Opinion vs reporting — The piece is explicitly presented as opinion.
The column strongly favors a libertarian, anti-regulatory framing, portraying the bill’s coverage mandate as government overreach and arguing for separation of medicine and state. It offers no substantial defense of the mandate.
- Framing — Frames insurance coverage requirements primarily as government intervention and cost shifting.
- Language tone — Uses dismissive language about Congress and presents the mandate as an imposition on everyone.
- Source selection — Relies on the columnist’s own argument and a brief quoted description of the bill.
A libertarian opinion column argues that the Ovarian Cancer IMPACT Act’s insurance-coverage mandate would spread genetic-testing costs across policyholders. The article identifies Sens. Elissa Slotkin and Katie Britt as leaders of the bill.
The column discusses the Ovarian Cancer IMPACT Act, which a report quoted in the article describes as requiring insurance plans to cover genetic testing for patients with hereditary risk factors and expanding gynecologic cancer education. The report identifies Sens. Elissa Slotkin and Katie Britt as leading the bill. The columnist says genetic testing can cost $250 to $500 and argues that mandated coverage would distribute those costs among policyholders.
Community verdict
2 VOTESPeople in this story
SWIPE →Part of a bigger story
3 OUTLETSSlotkin and Britt are backing a bipartisan Senate bill to improve ovarian cancer prevention, testing and care. Center outlets present the bill as an effort to expand prevention, testing and care; an opinion column instead argues its insurance mandate would spread genetic-testing costs across policyholders.
- ARTICLES
- 3
- OUTLETS
- 3
- AVG CRED
- 77
Discussion · 0
Loading comments…

